Physician profile
Daniel Felbaum
NPI 1013216472
$3,301.95
in general payments reported to CMS, 2019-2025
11 companies · $748 in 2025
The $748 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $15.44 · 2021: $72.73 · 2022: $995 · 2023: $639 · 2024: $556 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601 · Travel and Lodging: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,601.48 |
| Travel and Lodging | $341.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,478.27 | 2019-2025 | Axs Vecta 71, Universal Neuro 3, Everest Spinal System |
| Supreme Orthopedic Systems, LLC | $316.02 | 2025 | |
| Microvention, INC. | $312.78 | 2024 | Stent, Web Aneurysm Embolization System, Azur Cx Detachable |
| Baxter Healthcare | $211.28 | 2023 | Floseal |
| Arthrex, INC. | $209.95 | 2025 | |
| Longeviti Neuro Solutions INC | $209.14 | 2023 | |
| Globus Medical, INC. | $177.64 | 2023 | Excelsiusgps Robotic Navigation System, Excelsius3d Imaging System, Creo 5.5 |
| Integra Lifesciences Corporation | $168.96 | 2022 | |
| Brainlab, INC. | $98.78 | 2025 | Brainlab, INC. |
| Balt USA, LLC | $93.97 | 2024 | Optima Coil System |
| Imperative Care, INC | $25.16 | 2023 | Zoom 88-T Large Distal Platform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Felbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.